Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
39075719 | 0 | Porres-Aguilar M, Rivera-Lebron B, Kim NH, et al. Vascular Disease Patient Information Page: Post-pulmonary embolism syndrome, CTEPD, and CTEPH. Vasc Med. 2024 Jul 29:1358863X241258957. doi: 10.1177/1358863X241258957. | |
38846991 | 0 | Del Toro Mijares R, Rojas Murguia A, Porres-Aguilar M, et al. Anticoagulation in the Management of Acute Pulmonary Embolism-A Review. Int J Angiol. 2024 Mar 12;33(2):95-100. doi: 10.1055/s-0044-1782537. eCollection 2024 Jun. | |
38153027 | 0 | Porres-Aguilar M, Najera C, Mares AC, et al. Successful Treatment With the Oral Factor Xa Inhibitor Edoxaban in Heparin-Induced Thrombocytopenia With Thrombosis. Angiology. 2023 Dec 28:33197231225291. doi: 10.1177/00033197231225291. | |
38089875 | 0 | Jerjes-Sanchez C, Porres-Aguilar M. Editorial: Pulmonary embolism-New diagnostic and therapeutic strategies. Front Med (Lausanne). 2023 Nov 28;10:1281073. doi: 10.3389/fmed.2023.1281073. eCollection 2023. | |
37947131 | 0 | Prakash S, Mares AC, Porres-Aguilar M, et al. Factor XI/XIa inhibitors for the prevention and treatment of venous and arterial thromboembolism: A narrative review. Vasc Med. 2023 Nov 10:1358863X231206778. doi: 10.1177/1358863X231206778. | |
37576730 | 0 | Dah K, Porres-Aguilar M, la Rosa A, et al. Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism. J Vasc Bras. 2023 Jun 30;22:e20230056. doi: 10.1590/1677-5449.202300562. eCollection 2023. | |
37416093 | 0 | Porres-Aguilar M. ThromboprophylaXIs with Factor XI/XIa inhibitors for venous thromboembolism. J Vasc Bras. 2023 Jun 19;22:e20230051. doi: 10.1590/1677-5449.202300512. eCollection 2023. | |
36522193 | 0 | Porres-Aguilar M. Factor XI Inhibitors for the Prevention of Thrombosis: Towards Safer Anticoagulation Strategies. Arch Med Res. 2022 Dec 13:S0188-4409(22)00165-5. doi: 10.1016/j.arcmed.2022.11.018. | |
36481128 | 0 | Porres-Aguilar M, Ansell J, Mukherjee D, et al. Impact of Hospital-based Multidisciplinary Anticoagulation Stewardship Programs. Arch Med Res. 2022 Dec 5:S0188-4409(22)00163-1. doi: 10.1016/j.arcmed.2022.11.016. | |
36076354 | 0 | Porres-Aguilar M, Mukherjee D, Didia SC, et al. Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? current controversies. Vascular. 2022 Sep 8:17085381221126235. doi: 10.1177/17085381221126235. | |
35895858 | 0 | Porres-Aguilar M, Rosovsky RP, Rivera-Lebron BN, et al. Pulmonary embolism response teams: Changing the paradigm in the care for acute pulmonary embolism. J Thromb Haemost. 2022 Jul 27. doi: 10.1111/jth.15832. | |
35809961 | 0 | Porres-Aguilar M, Mukherjee D, Lazo-Langner A. Thromboprophylaxis Strategies for Hospitalized Patients With COVID-19. Chest. 2022 Jul;162(1):e69-e70. doi: 10.1016/j.chest.2022.03.038. | |
35759737 | 0 | Porres-Aguilar M, Anaya-Ayala JE. [Comment on article "Enoxaparin dose associated with decreased risk of death in COVID-19"]. Rev Med Inst Mex Seguro Soc. 2022 May 2;60(3):247-248. | |
34729195 | 0 | Porres-Aguilar M, Auron M, de Leon MCG. Klippel-Trenaunay and pregnancy. Oxf Med Case Reports. 2021 Oct 26;2021(10):omab096. doi: 10.1093/omcr/omab096. eCollection 2021 Oct. | |
34571100 | 0 | Aguilar-Piedras MF, Porres-Aguilar M, Mukherjee D, et al. High Flow Nasal Cannula Oxygenation Successfully Used as Bridge Therapy for Systemic Thrombolysis in COVID-19 Associated Intermediate-high Risk Pulmonary Embolism. Curr Probl Cardiol. 2021 Sep 24:101000. doi: 10.1016/j.cpcardiol.2021.101000. | |
34274156 | 0 | Porres-Aguilar M, Perez-Nieto OR, Zamarron-Lopez EI, et al. Thromboprophylaxis strategies for COVID-19 patients. Arch Med Res. 2022 Jan;53(1):109-110. doi: 10.1016/j.arcmed.2021.06.011. Epub 2021 Jul 5. | |
34235393 | 0 | Porres-Aguilar M, Mukherjee D. May-Thurner Syndrome in Pregnancy-Associated Venous Thromboembolism. TH Open. 2021 Jul 4;5(3):e251-e252. doi: 10.1055/s-0041-1731710. eCollection 2021 Jul. | |
34039677 | 0 | Porres-Aguilar M, Tapson VF, Rivera-Lebron BN, et al. Impact and role of pulmonary embolism response teams in venous thromboembolism associated with COVID-19. J Investig Med. 2021 Aug;69(6):1153-1155. doi: 10.1136/jim-2021-001856. Epub 2021 May 26. | |
33940219 | 0 | Porres-Aguilar M, Lazo-Langner A, Panduro A, et al. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis. Ann Hepatol. 2021 Jul-Aug;23:100356. doi: 10.1016/j.aohep.2021.100356. Epub 2021 Apr 30. | |
33835334 | 0 | Porres-Aguilar M, Hoeper MM, Rivera-Lebron BN, et al. Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension. J Thromb Thrombolysis. 2021 Oct;52(3):791-796. doi: 10.1007/s11239-021-02445-z. Epub 2021 Apr 9. | |
33719953 | 0 | Rodriguez JJ, Munoz OC, Porres-Aguilar M, et al. Thromboembolic Complications in Severe COVID-19: Current Antithrombotic Strategies and Future Perspectives. Cardiovasc Hematol Disord Drug Targets. 2021;21(1):23-29. doi: 10.2174/1871529X21666210315123347. | |
33459726 | 0 | Guillermo-Esposito C, Casais P, Cesarman-Maus G, et al. Guidelines for prophylaxis and anti-thrombotic treatment for patients with COVID-19. Consensus of the Latin American Cooperative Group on Hemostasis and Thrombosis (CLAHT) Arch Cardiol Mex. 2021 Dec 20;91(Suplemento COVID):047-054. doi: 10.24875/ACM.20000291. | |
33378786 | 0 | Le Mao R, Jimenez D, Bikdeli B, et al. Prognostic Impact of Obstructive Sleep Apnea in Patients Presenting with Acute Symptomatic Pulmonary Embolism. Thromb Haemost. 2021 Jun;121(6):808-815. doi: 10.1055/s-0040-1721506. Epub 2020 Dec 30. | |
33064698 | 0 | Carrillo-Esper R, Melgar-Bieberach RE, Tapia-Salazar M, et al. Manifestaciones extrapulmonares de la infeccion por SARS-CoV-2. Cir Cir. 2020;88(5):654-663. doi: 10.24875/CIRU.20000363. | |
33048811 | 0 | Porres-Aguilar M, Heresi GA, Anaya-Ayala JE, et al. [Pulmonary embolism or pulmonary thrombosis in situ in severe pneumonic COVID-19 associated coagulopathy: does systemic thrombolysis have a role?] Medicina (B Aires). 2020;80(5):581-582. | |
32497628 | 0 | Porres-Aguilar M, Anaya-Ayala JE, Mukherjee D, et al. Pulmonary embolism response teams in the challenging era of venous thromboembolism associated with COVID-19. J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):898-899. doi: 10.1016/j.jvsv.2020.04.032. Epub 2020 Jun 1. | |
32112537 | 0 | Porres-Aguilar M, Kahn SR, Hirsch AM. Direct oral anticoagulants in thrombotic antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2020 Mar;18(3):755-756. doi: 10.1111/jth.14705. | |
31761399 | 0 | Quezada A, Jimenez D, Bikdeli B, et al. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism. Int J Cardiol. 2020 Mar 1;302:157-163. doi: 10.1016/j.ijcard.2019.11.102. Epub 2019 Nov 14. | |
31593849 | 0 | Porres-Aguilar M, Anaya-Ayala JE, Jimenez D, et al. Pulmonary Embolism Response Teams: Pursuing Excellence in the Care for Venous Thromboembolism. Arch Med Res. 2019 Jul;50(5):257-258. doi: 10.1016/j.arcmed.2019.08.011. Epub 2019 Oct 5. |